ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - bacillus clausii -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

rf six pty ltd - humulus lupulus,nicotinamide,pyridoxine hydrochloride,passiflora incarnata,thiamine nitrate,valeriana officinalis,zinc sulfate monohydrate -

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

hospira enterprises b.v. - noradrenaline acid tartrate - concentrate for soln for inf - 1 mg/ml - adrenergic and dopaminergic agents

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

novocat farma s.a. - noradrenaline tartrate - concentrate for solution for infusion - 1 mg/ml - adrenergic and dopaminergic agents - it is indicated for the emergency restoration of blood pressure in cases of acute hypotension

المملكة المتحدة - الإنجليزية - myHealthbox

farma mediterrania s.l. - noradrenaline tartrate - concentrate for solution for infusion - 2mg/ml - adrenergic and dopaminergic agents - noradrenaline (norepinephrine) concentrate is indicated for the emergency restoration of blood pressure in cases of acute hypotension.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - noradrenaline tartrate - concentrate for solution for infusion - 1 milligram(s)/millilitre - adrenergic and dopaminergic agents; norepinephrine - adrenergic and dopaminergic agents - noradrenaline (norepinephrine) concentrate is indicated for the emergency restoration of blood pressure in cases of acute hypotension

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 2mg/2ml solution for infusion ampoules (pfizer ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/4ml concentrate for solution for infusion ampoules (pfizer ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - noradrenaline acid tartrate - concentrate for solution for infusion - 1 milligram(s)/millilitre - adrenergic and dopaminergic agents; norepinephrine

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - lincomycin hydrochloride monohydrate, quantity: 340.26 mg/ml (equivalent: lincomycin, qty 300 mg/ml) - injection, solution - excipient ingredients: benzyl alcohol; water for injections - indications as at 22 september 1994: lincocin is indicated in the treatment of serious infections due to susceptible strains of gram positive aerobes such as streptococci, pneumococci and staphylococci. its use should be reserved for penicillin allergic patients or other patients for whom, in the judgement of the physician, a penicillin is inappropriate. because of the risk of colitis (see precautions), before selecting lincomycin the physician should consider the nature of infection and the suitability of less toxic alternatives (e.g.erythromycin). lincocin has been demonstrated to be effective in the treatment of staphylococcal infections resistant to other antibiotics and susceptible to lincomycin. staphylococcal strains resistant to lincocin have been recovered; culture and susceptibility studies should be done in conjunction with lincocin therapy. in the case of macrolides, partial but not complete cross resistance may occur. the drug may be administered concomitantly with other antimicrobial agents with